STRIDE Study - A Study in Subjects With LOPD Who Are Currently Being Treated With ERT

TerminatedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

December 8, 2017

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Late-onset Pompe Disease
Trial Locations (21)

1650

Antwerp University Hospital, Edegem

5000

Royal Adelaide Hospital, Adelaide

10016

NYU Neurogenetics, New York

11021

Northwell Health, Great Neck

15261

University of Pittsburgh, Pittsburgh

17033

Penn State Hershey Medical Center, Hershey

27710

Duke University Medical Center, Durham

30033

Emory University, Decatur

32611

University of Florida Clinical Research Center, Gainesville

43210

Ohio State University, Columbus

45229

Cincinnati Children's Hospital, Cincinnati

55455

University of Minnesota Medical Center, Minneapolis

66160

University of Kansas Medical Center, Kansas City

78229

The University of Texas Health Science Center San Antonio, San Antonio

92868

University of California, Irvine, Irvine

97239

Oregon Health& Science University, Portland

01199

Baystate Medical Center, Springfield

07601

Hackensack University Medical Center, Hackensack

07960

Jacobs & Levy Genomic Medicine and Research Program, Morristown

Unknown

Alberta Children's Hospital, Calgary

McMaster University Medical Center, Hamilton

Sponsors
All Listed Sponsors
lead

Amicus Therapeutics

INDUSTRY

NCT03347253 - STRIDE Study - A Study in Subjects With LOPD Who Are Currently Being Treated With ERT | Biotech Hunter | Biotech Hunter